Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Backstitch wants to fix a billion-dollar communication dilemma
With the cost of poor business communication climbing as high as $37 billion a year, Backstitch founders Jordan and Stefanie Warzecha saw an opportunity to clear the air. The married couple — who say communication has never been a problem for them — founded their corporate communications platform in 2012. Backstitch aims to mitigate the…
Google Fiber names local duo as digital inclusion leaders
After a successful first year, Google Fiber — in partnership with the Nonprofit Technology Network — has announced its second round of Digital Inclusion Fellows. As part of the program, fellows will create and lead digital literacy efforts in the 11 metro areas with Google Fiber, including Kansas City. Initiatives include assisting adults with high…
Can downtowners ditch the Dodge? Zipcar expands in Kansas City
Downtown Kansas City residents have another compelling reason to become car-less converts. The on-demand car rental service Zipcar is expanding its area presence to Kansas City’s downtown, providing its growing population another flexible transportation option. The international car-sharing service is beefing up local offerings — which already includes two cars at Kansas City International Airport…
Plexpod Westport Commons exhumes obscured mural of Kansas City
For an update on this piece, click here. Amid the dust and drilling at the yet-to-be-open Plexpod Westport Commons is a little-known artistic gem for Kansas City. At the heart of a project that marries history and innovation, the colossal coworking facility that was formerly Westport Junior High features a vibrant — albeit deteriorating —…